alpha-aminopyridine has been researched along with Atherosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glass, CK; Li, D; Liao, Z; Saltiel, AR; Shen, Z; Sun, X; Witztum, JL; Yu, H; Zhao, P | 1 |
| Aouadi, M; Bhattacharya, SK; Buckbinder, L; Cooper, MP; Cortes, C; Czech, MP; Danai, LV; Fitzgibbons, TP; Hagan, N; Matevossian, A; Menendez, LG; Roth Flach, RJ; Skoura, A; Vangala, P; Yawe, JC; Zheng, W | 1 |
| Anto-Michel, N; Blanz, KD; Bode, C; Braddock, M; Dufner, B; Geis, S; Gerhardt, LM; Gilsbach, R; Härdtner, C; Hawley, S; Heidt, T; Hein, L; Hergeth, SP; Hilgendorf, I; Hoppe, N; Kornemann, J; Libby, P; Lindau, A; McPheat, W; Robbins, CS; Stachon, P; Swirski, FK; von zur Mühlen, C; Willecke, F; Wolf, D; Zirlik, A; Zou, J | 1 |
| Bode, C; Buchner, M; Colberg, C; Eisele, S; Hilgendorf, I; Hoppe, N; Lozhkin, A; Ortiz-Rodriguez, A; Remer, I; Schmitz, J; Stachon, P; von zur Muhlen, C; Willecke, F; Wolf, D; Zeschky, K; Zirlik, A; Zirlik, K; zur Hausen, A | 1 |
4 other study(ies) available for alpha-aminopyridine and Atherosclerosis
| Article | Year |
|---|---|
The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis.
Topics: Aminopyridines; Animals; Atherosclerosis; Bile Acids and Salts; Diabetes Mellitus, Experimental; Humans; Hypercholesterolemia; I-kappa B Kinase; Mice; Protein Serine-Threonine Kinases | 2022 |
Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis.
Topics: Aminopyridines; Animals; Apolipoproteins E; Atherosclerosis; Endothelial Cells; Gene Expression Regulation; Inflammation; Macrophages; Male; Mice; Mice, Knockout; NF-kappa B; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Receptors, LDL; Vascular Diseases | 2015 |
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.
Topics: Aminopyridines; Animals; Atherosclerosis; Cell Adhesion; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Female; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Monocytes; Morpholines; Myelopoiesis; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Random Allocation; Syk Kinase | 2016 |
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
Topics: Administration, Oral; Aminopyridines; Animals; Atherosclerosis; Cell Differentiation; Cell Movement; Cholesterol, Dietary; Inflammation; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Morpholines; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Receptors, LDL; Syk Kinase | 2011 |